April 27, 2020 by Chain Drug Review
chief executive officer B. Douglas Hoey, COVID-19, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — As the coronavirus pandemic continues straining small business independent community pharmacies, 115 members of the U.S. House of Representatives are supporting a bipartisan push to include language permanently prohibiting pharmacy direct and indirect remuneration clawbacks by pharmacy benefit managers in future coronavirus relief packages. The letter was led by Reps. Buddy Carter
April 27, 2020 by Andrea Leigh
Andrea Leigh, COVID-19, IdeoClick
April 27, 2020, Opinion
The worldwide COVID-19 pandemic has affected our personal lives, businesses, schools, health care systems, government and shopping behaviors. As retailers and manufacturers on the front line, we face real, daily challenges. How do we get more hand sanitizer into the stores? Should we pivot our manufacturing to produce toilet paper and cleaning products? How do
April 27, 2020 by Chain Drug Review
Cindy McDaniel, COVID-19, GSK, Jissan Cherian, Voltaren Arthritis Pain
Supplier News
WARREN, N.J.— GlaxoSmithKline recently announced a multi-year partnership with the Arthritis Foundation to support scientific research, advocacy as well as virtual resources and community connections for the more than 30 million people in America living with osteoarthritis (OA). As part of the mission for an osteoarthritis cure, Voltaren Arthritis Pain is donating 100% of profits
April 27, 2020 by Chain Drug Review
Blueprint for Shopping Safe, COVID-19, National Retail Federation (NR, NRF president and chief executive officer Matthew Shay, RILA president Brian Dodge, The Retail Industry Leaders Association (RILA) a
Business, Featured Articles, Leading Headlines, Retail News
WASHINGTON — The Retail Industry Leaders Association (RILA) and the National Retail Federation (NRF) released on Monday a Blueprint for Shopping Safe outlining a phased-in approach to reopening retail. The plan urges governors to issue uniform, statewide protocols for retailers to adopt as they reopen stores and work to keep employees and customers safe. “As
April 27, 2020 by Chain Drug Review
COVID-19, Dr. Roger Perlmutter, Institute for Systems Biology (ISB), Merck, Merck Vaccines
Leading Headlines, Pharmacy
KENILWORTH, N.J. — Merck and the Institute for Systems Biology (ISB), announced on Monday a new research collaboration to investigate and define the molecular mechanisms of SARS-CoV-2 infection and COVID-19 and identify targets for medicines and vaccines. Merck has also entered into an agreement with the Biomedical Advanced Research and Development Authority (BARDA), part of
April 27, 2020 by Wendy Liebmann
COVID-19, emerging retail technologies, Wendy Liebmann
April 27, 2020, Opinion
When I first set out to write this, the U.S. was a very different place. We are now at a moment that calls to mind the opening lines of Charles Dickens’ A Tale of Two Cities. “It was the best of times, it was the worst of times, it was the age of wisdom, it
April 27, 2020 by Jeffrey Woldt
COVID-19, pharmacy
April 27, 2020, Opinion
As the nation’s health care system has come under intense scrutiny during the COVID-19 pandemic, doctors, nurses and hospital systems, especially those dealing directly with coronavirus patients, have earned accolades for their heroic efforts to save lives and restore health. Two other components of the health care system — one routinely undervalued, the other often
April 26, 2020 by Chain Drug Review
B. Douglas Hoey, COVID-19, Gov. Andrew Cuomo, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association, which represents over 21,000 independent pharmacies across the country, issued the following statement on behalf of CEO B. Douglas Hoey in response to New York Governor Andrew Cuomo’s executive order authorizing New York’s small business independent pharmacies to serve as COVID-19 testing collection centers: “We are deeply
April 24, 2020 by Chain Drug Review
COVID-19, Florida Gov. DeSantis, Gov. DeSantis, NACDS, NACDS president and chief executive officer Steven Anderson
Leading Headlines, Pharmacy
ARLINGTON, Va. — National Association of Chain Drug Stores (NACDS) president and CEO Steven Anderson, issued the following statement Friday on Florida Gov. DeSantis COVID-19 testing action: “Throughout this crisis, Gov. DeSantis has been one of the true leaders across the nation in helping to remove barriers so pharmacies and pharmacists can help to meet
April 23, 2020 by Chain Drug Review
Blake Thompson, COVID-19, Feeding America, Gerber
Supplier News
ARLINGTON, Va. — Gerber reported that its annual donation of baby food products to Feeding America increased to more than $2.8 million to support those in need. As COVID-19 impacts the health and financial security of American families, it has donated more than $687,000 of baby food to Feeding America for the months of March and April
April 23, 2020 by Chain Drug Review
000 new full-service shoppers, 250, Apoorva Mehta, COVID-19, Instacart
Leading Headlines, Retail News
SAN FRANCISCO — Instacart announced plans to introduce additional safety measures for its growing shopper community including new in-app shopper wellness checks as well as the expansion of its COVID-19 extended pay policies for all shoppers and bonuses for in-store teams. The company also announced its plans to bring on an additional 250,000 full-service shoppers
April 23, 2020 by Clint Mahlman
Clint Mahlman, COVID-19, London Drugs
April 13, 2020, April 27, 2020, Featured Articles, Leading Headlines, Opinion
Editor’s note: This is part of a series of articles on how retailers are responding to the COVID-19 crisis. London Drugs of Richmond, British Columbia, has been responding significantly to the COVID-19 crisis. In Canada, food and pharmacy retail is deemed an essential service, and the government requires the stores to stay open. That creates
April 23, 2020 by Chain Drug Review
Cherylann Pinto, COVID-19, Glenmark Foundation, Glenmark Pharmaceuticals
Pharmacy, Supplier News
MUMBAI, India — As millions across the country grapple with the COVID-19 pandemic, Glenmark Foundation, the CSR arm of Glenmark Pharmaceuticals along with its NGO partners, is working closely in alignment with government directives and state health authorities to extend its support – through a combination of on-ground and remote health initiatives. Glenmark’s community outreach
April 22, 2020 by Chain Drug Review
COVID-19, COVID-19 National Data Resource Center, Josh Schoeller, LexisNexis Risk Solutions
Leading Headlines, Pharmacy, Supplier News
ATLANTA — The Health Care business of LexisNexis Risk Solutions has launched a free COVID-19 Data Resource Center to provide county-level insights on at-risk populations and potential care capacity gaps to support the U.S. healthcare industry’s response to the COVID-19 pandemic. By combining its own data and analytics with those of other industry stakeholders, the company created insights